Use of 9-deoxy prostaglandin derivatives to treat glaucoma
AssigneeAlcon Laboratories, Inc.
InventorsMark R. Hellberg, Thomas R. Dean, Paul W. Zinke, Robert D. Selliah, John E. Bishop
Life of this patent
Estimating the term…
Abstract
Disclosed are 9-deoxyprostaglandins which are useful in the treatment of glaucoma and ocular hypertension. Some of these 9-deoxyprostaglandins are novel. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.
Claims15
A method of treating glaucoma and ocular hypertension which comprises topically administering to the affected eye a therapeutically effective amount of a compound of formula:
- ##STR12## wherein:
- Y=C(O)NR.sub.1 R.sub.2, CH.sub.2 OR.sub.3, CH.sub.2 NR.sub.1 R.sub.2, CO.sub.2 R.sub.1, CO.sub.2 M where M is a cationic salt moiety;
- R.sub.1, R.sub.2 (same or different)=H, C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- R, R.sub.3 (same or different)=C(O)R.sub.4, H;
- R.sub.4 =C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- X=O, S(O).sub.n, CH.sub.2 ;
- n=0, 1, or 2;
- A=CH.sub.2 CH.sub.2, cis or trans CH.dbd.CH, or C.tbd.C;
- Z=CH.sub.2 CH.sub.2, trans CH.dbd.CH, or C.tbd.C;
- W=(CH.sub.2).sub.m, Aryl, (CH.sub.2).sub.m OAryl where m=1-6 and Aryl=phenyl, optionally substituted with halogen, hydroxy, alkoxy, haloalkyl, amino, or acylamino;
- or ##STR13## where V=H, alkyl, halogen, hydroxy, alkoxy, acryloxy, haloalkyl, amino, acylamino, and L=CH.sub.2, O, S(O).sub.m, CH.sub.2 CH.sub.2, CH.sub.2 O, NR, CH.dbd.N, CH.sub.2 S(O).sub.m, CH.dbd.CH, CH.sub.2 NR where m=0-2 and R is as defined above.
A topical ophthalmic composition for the treatment of glaucoma and ocular hypertension, said composition comprising an ophthalmically acceptable vehicle and a therapeutically effective amount of a compound of formula:
- ##STR14## wherein:
- Y=C(O)NR.sub.1 R.sub.2, CH.sub.2 OR.sub.2, CH.sub.2 NR.sub.1 R.sub.2, CO.sub.2 R.sub.1, CO.sub.2 M where M is a cationic salt moiety;
- R.sub.1, R.sub.2 (same or different)=H, C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- R, R.sub.3 (same or different)=C(O)R.sub.4, H;
- R.sub.4 =C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- X=O, S(O).sub.n, CH.sub.2 ;
- n=0, 1, or 2;
- A=CH.sub.2 CH.sub.2 cis or trans CH.dbd.CH, or C.tbd.C;
- Z:
- CH.sub.2 CH.sub.2, trans CH.dbd.CH, or C.tbd.C;
- W=(CH.sub.2).sub.m Aryl, (CH.sub.2).sub.m OAryl where m=1-6 and Aryl=phenyl, optionally substituted with halogen, hydroxy, alkoxy, haloalkyl, amino, or acylamino;
- or ##STR15## where V=H, alkyl, halogen, hydroxy, alkoxy, acryloxy, haloalkyl, amino, acylamino, and L=CH.sub.2, O, S(O).sub.m, CH.sub.2 CH.sub.2, CH.sub.2 O, NR, CH.dbd.N, CH.sub.2 S(O).sub.m, CH.dbd.CH, CH.sub.2 NR where m=0-2 and R is as defined above.
A compound of formula:
- ##STR16## wherein:
- Y=C(O)NR.sub.1 R.sub.2, CH.sub.2 OR.sub.3, or CH.sub.2 NR.sub.1 R.sub.2 ;
- R.sub.1, R.sub.2 (same or different)=H, C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- R, R.sub.3 (same or different)=C(O)R.sub.4, H;
- R.sub.4 =C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- X=O, S(O).sub.n, or CH.sub.2 ;
- n=0, 1, or2;
- A=CH.sub.2 CH.sub.2, cis or trans CH.dbd.CH, or C.tbd.C;
- Z=CH.sub.2 CH.sub.2, trans CH.dbd.CH, or C.tbd.C;
- W=(CH.sub.2).sub.m Aryl or (CH.sub.2).sub.m OAryl;
- m=1-6;
- and
- Aryl=phenyl, optionally substituted with halogen, hydroxy, alkoxy, haloalkyl, amino, or acylamino;
- with the proviso that the following compounds be excluded:
- ##STR17## wherein:
- A=CH.sub.2 CH.sub.2 or CH.dbd.CH;
- Z=CH.sub.2 CH.sub.2 or trans- CH.dbd.CH;
- W=CH.sub.2 OAryl or (CH.sub.2).sub.m Aryl, wherein m=2 or 3, and Aryl=phenyl, optionally substituted with halogen, hydroxy, alkoxy, or haloalkyl.
A compound of the formula:
- ##STR18## wherein:
- Y=C(O)NR.sub.1 R.sub.2, CH.sub.2 OR.sub.3, CH.sub.2 NR.sub.1 R.sub.2, CO.sub.2 R.sub.1, CO.sub.2 M where M is a cationic salt moiety;
- R.sub.1, R.sub.2 (same or different)=H, C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- R, R.sub.3 (same or different)=C(O)R.sub.4, H;
- R.sub.4 =C.sub.1 -C.sub.6 alkyl or alkenyl, or C.sub.3 -C.sub.6 cycloalkyl;
- X=O, S(O).sub.n, CH.sub.2 ;
- n=0, 1, or 2;
- A=CH.sub.2 CH.sub.2, cis or trans CH.dbd.CH, or C.tbd.C;
- Z=CH.sub.2 CH.sub.2, trans CH.dbd.CH, or C.tbd.C;
- ##STR19## V=H, alkyl, halogen, hydroxy, alkoxy, acryloxy, haloalkyl, amino, acylamino, and L=CH.sub.2, O, S(O).sub.m, CH.sub.2 CH.sub.2, CH.sub.2 O, NR, CH.dbd.N, CH.sub.2 S(O).sub.m, CH.dbd.CH, CH.sub.2 NR where m=0-2 and R is as defined above.
Dependencies are inferred from the claim text.